Misha Mao
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- Cancer, Lipids, and Metabolism 3
Misha Mao
20 papers receiving 767 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 373
- Pulmonary and Respiratory Medicine 399
- Molecular Biology 511
- Oncology 111
- Immunology 69
Countries citing papers authored by Misha Mao
This map shows the geographic impact of Misha Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misha Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misha Mao more than expected).
Fields of papers citing papers by Misha Mao
This network shows the impact of papers produced by Misha Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misha Mao. The network helps show where Misha Mao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Misha Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 11 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 17 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 24 | |
| 8 | 2022 | 25 | |
| 9 | 2022 | 44 | |
| 10 | 2022 | 28 | |
| 11 | 2021 | 20 | |
| 12 | 2021 | 14 | |
| 13 | Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer Hit paper breakdown → | 2021 | 270 |
| 14 | 2021 | 13 | |
| 15 | 2021 | 3 | |
| 16 | 2021 | 20 | |
| 17 | 2020 | 150 | |
| 18 | 2019 | 31 | |
| 19 | 2018 | 25 | |
| 20 | 2018 | 6 |
About Misha Mao
Misha Mao is a scholar working on Cancer Research, Molecular Medicine, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 768 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), Kruppel-like factors research (5 papers), RNA modifications and cancer (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Cancer, Lipids, and Metabolism (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer-related gene regulation (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (373 citations), Pulmonary and Respiratory Medicine (399 citations), Molecular Biology (511 citations), Oncology (111 citations) and Immunology (69 citations). Misha Mao has collaborated with scholars based in China, France and Italy. Frequent co-authors include Yongxia Chen, Linbo Wang, Jichun Zhou, Xun Zhang, Zhaoqing Li, Yulu Zhou, Jingjing Yang, Lini Chen, Cong Chen and Aihua Huang. Their work appears in journals such as Biomarker Research, Cell Death and Disease, Frontiers in Cell and Developmental Biology, Journal for ImmunoTherapy of Cancer and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.